These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17214026)

  • 21. Optimal branch selection in alcohol septal ablation.
    Toutouzas K; Karanasos A; Anastasakis A; Vavuranakis M; Seggewiss H; Stefanadis C; Rigopoulos A
    Int J Cardiol; 2011 Feb; 147(1):143-4. PubMed ID: 19910065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques.
    Luckie M; Khattar RS
    Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 24. Conservative versus invasive treatment in hypertrophic obstructive cardiomyopathy: an echocardiography study.
    Honek T; Krejci J; Machal J; Groch L; Sitar J; Meluzin J; Spinarova L
    Bratisl Lek Listy; 2016; 117(10):562-570. PubMed ID: 27826970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol ablation for mid-ventricular obstruction: straying from the path of righteousness?
    Sigwart U
    Eur J Echocardiogr; 2000 Dec; 1(4):227-8. PubMed ID: 11916597
    [No Abstract]   [Full Text] [Related]  

  • 26. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Duchonová R; Procházková S; Homolová I; Pálenícková J; Zemánek D; Pernisová Z; Tesar D
    Kardiol Pol; 2004 Feb; 60(2):133-6; discussion 137. PubMed ID: 15116158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter alcohol ablation of the septum in a patient of hypertrophic obstructive cardiomyopathy.
    Bhargava B; Agarwal R; Kaul U; Manchanda SC; Wasir HS
    Cathet Cardiovasc Diagn; 1997 May; 41(1):56-8. PubMed ID: 9143769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
    Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
    Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy.
    Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
    Turk Kardiyol Dern Ars; 2017 Jan; 45(1):67-72. PubMed ID: 28106021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Haghjoo M
    J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    El-Sabawi B; Nishimura RA; Guerrero ME; Rihal CS; Eleid MF
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):830-837. PubMed ID: 31410979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracardiac echocardiography guidance for alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Alfonso F; Martín D; Fernández-Vázquez F
    J Invasive Cardiol; 2007 May; 19(5):E134-6. PubMed ID: 17470972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
    Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography.
    Breithardt OA; Beer G; Stolle B; Lieder F; Franke A; Lawrenz T; Hanrath P; Kuhn H
    Heart; 2005 Mar; 91(3):379-80. PubMed ID: 15710730
    [No Abstract]   [Full Text] [Related]  

  • 38. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
    Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
    Kitamura M; Takayama M; Matsuda J; Kubota Y; Nakamura S; Takano H; Asai K; Shimizu W
    Am J Cardiol; 2015 Sep; 116(6):945-51. PubMed ID: 26209114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ablation of hypertrophic septum using radiofrequency energy: an alternative for gradient reduction in patient with hypertrophic obstructive cardiomyopathy?
    Riedlbauchová L; Janoušek J; Veselka J
    J Invasive Cardiol; 2013 Jun; 25(6):E128-32. PubMed ID: 23735367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.